Out of stock

This item is currently unavailable

Gone for 76 days. Could come back at any time — we're watching for you.

Out of stock 76 days

World Outlook for Hepatitis C Drugs 2025-2030 Report

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 76 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

The 2025-2030 World Outlook for Hepatitis C Drugs provides a detailed analysis of the pharmaceutical landscape for the coming years. Published by ICON Group International, Inc., this book offers professional insights into the evolving market for Hepatitis C treatments. It serves as a specialized resource for those studying market trends and drug developments within the medical field. This publication is an essential addition to any professional library focused on global healthcare trends and pharmaceutical outlooks.

Key Features

Covers the specific market outlook for Hepatitis C drugs from 2025 through 2030.

Published by ICON Group International, Inc. for professional use.

Provides specialized knowledge within the medical and pharmaceutical book category.

Offers a comprehensive look at the global landscape for Hepatitis C treatments.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
29 April 2024

Similar Products You Might Like

The 2025-2030 World Outlook for Hepatitis C Therapies
99% match

The 2025-2030 World Outlook for Hepatitis C Therapies

Price unavailable
World Outlook for Hepatitis C Therapeutics 2025-2030
99% match

World Outlook for Hepatitis C Therapeutics 2025-2030

Price unavailable
The 2025-2030 World Outlook for Hepatitis C Treatments
99% match

The 2025-2030 World Outlook for Hepatitis C Treatments

Price unavailable
The 2013-2018 Outlook for Hepatitis C Virus (HCV) Therapeutics in India
97% match

The 2013-2018 Outlook for Hepatitis C Virus (HCV) Therapeutics in India

£495.00 31 Oct 2026
World Outlook: Viral Hepatitis and Retrovirus Diagnostic Tests
97% match

World Outlook: Viral Hepatitis and Retrovirus Diagnostic Tests

Price unavailable
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China
97% match

The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China

£595.00 26 Aug 2026
The 2023-2028 World Outlook for Hepatitis B Diagnostic Tests
97% match

The 2023-2028 World Outlook for Hepatitis B Diagnostic Tests

Price unavailable
Hepatitis C Virus (HCV) Therapeutics Outlook 2016-2021 Study
96% match

Hepatitis C Virus (HCV) Therapeutics Outlook 2016-2021 Study

£595.00 28 Oct 2026
World Outlook for Generic Antiviral Drugs 2025-2030 Study
96% match

World Outlook for Generic Antiviral Drugs 2025-2030 Study

Price unavailable
World Outlook for Hepatitis B Vaccines 2025-2030 Book
96% match

World Outlook for Hepatitis B Vaccines 2025-2030 Book

Price unavailable
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
96% match

The 2025-2030 World Outlook for Liver Cirrhosis Drugs

Price unavailable
Hepatitis B Diagnostic Test Outlook in India 2023-2028
96% match

Hepatitis B Diagnostic Test Outlook in India 2023-2028

£515.00 04 Nov 2026
Hepatitis C: From Infection to Cure
96% match

Hepatitis C: From Infection to Cure

IntechOpen

£113.24 10 Oct 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
96% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 27 Aug 2026
The 2023-2028 World Outlook for Hepatitis B Vaccines
96% match

The 2023-2028 World Outlook for Hepatitis B Vaccines

Price unavailable
The 2023-2028 Outlook for Antiviral Drugs in India
96% match

The 2023-2028 Outlook for Antiviral Drugs in India

£515.00 26 Aug 2026
The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in China
96% match

The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in China

£495.00 04 Nov 2026
The 2023-2028 Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests in Japan
96% match

The 2023-2028 Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests in Japan

£495.00 28 Aug 2026
Hepatitis B Diagnostic Test Outlook 2023-2028 - US Study
96% match

Hepatitis B Diagnostic Test Outlook 2023-2028 - US Study

£490.00 05 Nov 2026
Systemic Antiviral Pharmaceuticals Outlook Greater China
96% match

Systemic Antiviral Pharmaceuticals Outlook Greater China

£595.00 07 Nov 2026
The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in Japan
96% match

The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in Japan

£495.00 25 Aug 2026
World Outlook for Liver Disease Treatments 2025-2030
96% match

World Outlook for Liver Disease Treatments 2025-2030

Price unavailable
World Outlook for Oncolytic Virus Immunotherapies 2025-2030
96% match

World Outlook for Oncolytic Virus Immunotherapies 2025-2030

Price unavailable
Hepatitis B Vaccine Outlook 2023-2028 - US Market Study
96% match

Hepatitis B Vaccine Outlook 2023-2028 - US Market Study

£520.00 03 Nov 2026